Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fennec Pharmaceuticals Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
FENC
Nasdaq
2830
www.fennecpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
- Feb 7th, 2025 12:00 pm
Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales
- Dec 20th, 2024 11:16 am
Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management
- Dec 19th, 2024 11:13 am
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
- Dec 12th, 2024 12:01 pm
Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
- Nov 12th, 2024 10:31 am
Fennec Pharmaceuticals Inc (FENC) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...
- Nov 9th, 2024 7:00 am
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
- Nov 7th, 2024 11:13 am
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
- Oct 31st, 2024 10:23 am
Individual investors account for 31% of Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) ownership, while hedge funds account for 30%
- Oct 29th, 2024 10:34 am
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
- Oct 28th, 2024 10:23 am
The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable
- Oct 1st, 2024 10:35 am
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
- Sep 5th, 2024 10:56 am
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This Year
- Aug 21st, 2024 10:25 am
Fennec Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations
- Aug 15th, 2024 10:41 am
Q2 2024 Fennec Pharmaceuticals Inc Earnings Call
- Aug 14th, 2024 5:57 am
Fennec Q2 Loss Stays Constant as Revenue More Than Doubles, Appoints Jeffrey Hackman as CEO
- Aug 13th, 2024 11:19 am
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Aug 13th, 2024 10:05 am
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
- Aug 6th, 2024 8:31 pm
Update On Canada Stocks To Watch: Hut 8, Bitfarms; Emera; Energy Fuels; Fennec; Gran Tierra; Golden Minerals; Nuvei; Altius Renewable, Aura Minerals; 5N Plus, Green Thumb
- Aug 6th, 2024 12:09 am
Canada Stocks To Watch: Bitfarms; Emera; Energy Fuels; Fennec; Gran Tierra; Golden Minerals; Nuvei; Altius Renewable, Aura Minerals; 5N Plus, Green Thumb
- Aug 6th, 2024 12:01 am
Scroll